Compare Nasdaq Inc (NDAQ) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq Inc vs 10X Genomics Inc — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Nasdaq Inc is far larger — about 9.5× 10X Genomics Inc's market cap, and Nasdaq Inc pays a 1.22% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| NDAQ | TXG | |
|---|---|---|
Market Cap | $51.96B | $5.48B |
Sector | Financials | Health |
52-Week High | $100.98 | $45.80 |
52-Week Low | $76.85 | $11.34 |
Enterprise Value | $59.02B | $5.02B |
Dividend Yield | 1.22% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
